Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Biofeedback treatment for Tourette syndrome: a preliminary randomized controlled trial.

Nagai Y, Cavanna AE, Critchley HD, Stern JJ, Robertson MM, Joyce EM.

Cogn Behav Neurol. 2014 Mar;27(1):17-24. doi: 10.1097/WNN.0000000000000019.

PMID:
24674962
[PubMed - indexed for MEDLINE]
2.

Coprolalia and copropraxia in patients with Gilles de la Tourette syndrome.

Kobierska M, Sitek M, Gocyła K, Janik P.

Neurol Neurochir Pol. 2014 Jan-Feb;48(1):1-7. doi: 10.1016/j.pjnns.2013.03.001. Epub 2014 Jan 23.

PMID:
24636763
[PubMed - indexed for MEDLINE]
3.

Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.

Egolf A, Coffey BJ.

Drugs Today (Barc). 2014 Feb;50(2):159-79. doi: 10.1358/dot.2014.50.2.2097801. Review.

PMID:
24619591
[PubMed - indexed for MEDLINE]
4.

Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

Castellan Baldan L, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza KE, Ercan-Sencicek AG, Krusong K, Leventhal BL, Ohtsu H, Bloch MH, Hughes ZA, Krystal JH, Mayes L, de Araujo I, Ding YS, State MW, Pittenger C.

Neuron. 2014 Jan 8;81(1):77-90. doi: 10.1016/j.neuron.2013.10.052.

PMID:
24411733
[PubMed - indexed for MEDLINE]
5.

Preface: the metamorphoses of Gilles de la Tourette syndrome.

Martino D, Cavanna AE.

Int Rev Neurobiol. 2013;112:xv-xx. doi: 10.1016/B978-0-12-411546-0.10000-9. No abstract available.

PMID:
24295632
[PubMed - indexed for MEDLINE]
6.

Emerging treatment strategies in Tourette syndrome: what's in the pipeline?

Termine C, Selvini C, Rossi G, Balottin U.

Int Rev Neurobiol. 2013;112:445-80. doi: 10.1016/B978-0-12-411546-0.00015-9. Review.

PMID:
24295630
[PubMed - indexed for MEDLINE]
7.

Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome.

Rizzo R, Gulisano M.

Int Rev Neurobiol. 2013;112:415-44. doi: 10.1016/B978-0-12-411546-0.00014-7. Review.

PMID:
24295629
[PubMed - indexed for MEDLINE]
8.

Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome.

Neri V, Cardona F.

Int Rev Neurobiol. 2013;112:391-414. doi: 10.1016/B978-0-12-411546-0.00013-5. Review.

PMID:
24295628
[PubMed - indexed for MEDLINE]
9.

Antiepileptic drugs and Tourette syndrome.

Cavanna AE, Nani A.

Int Rev Neurobiol. 2013;112:373-89. doi: 10.1016/B978-0-12-411546-0.00012-3. Review.

PMID:
24295627
[PubMed - indexed for MEDLINE]
10.

Clinical pharmacology of nondopaminergic drugs in Tourette syndrome.

Hartmann A.

Int Rev Neurobiol. 2013;112:351-72. doi: 10.1016/B978-0-12-411546-0.00011-1. Review.

PMID:
24295626
[PubMed - indexed for MEDLINE]
11.

Neuroendocrine aspects of Tourette syndrome.

Martino D, Macerollo A, Leckman JF.

Int Rev Neurobiol. 2013;112:239-79. doi: 10.1016/B978-0-12-411546-0.00009-3. Review.

PMID:
24295624
[PubMed - indexed for MEDLINE]
12.

Animal models recapitulating the multifactorial origin of Tourette syndrome.

Macrì S, Onori MP, Roessner V, Laviola G.

Int Rev Neurobiol. 2013;112:211-37. doi: 10.1016/B978-0-12-411546-0.00008-1. Review.

PMID:
24295623
[PubMed - indexed for MEDLINE]
13.

Genetic susceptibility and neurotransmitters in Tourette syndrome.

Paschou P, Fernandez TV, Sharp F, Heiman GA, Hoekstra PJ.

Int Rev Neurobiol. 2013;112:155-77. doi: 10.1016/B978-0-12-411546-0.00006-8. Review.

PMID:
24295621
[PubMed - indexed for MEDLINE]
14.

Reinforcement learning and Tourette syndrome.

Palminteri S, Pessiglione M.

Int Rev Neurobiol. 2013;112:131-53. doi: 10.1016/B978-0-12-411546-0.00005-6. Review.

PMID:
24295620
[PubMed - indexed for MEDLINE]
15.

Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome.

Udvardi PT, Nespoli E, Rizzo F, Hengerer B, Ludolph AG.

Int Rev Neurobiol. 2013;112:95-130. doi: 10.1016/B978-0-12-411546-0.00004-4. Review.

PMID:
24295619
[PubMed - indexed for MEDLINE]
16.

Functional imaging of dopaminergic neurotransmission in Tourette syndrome.

Segura B, Strafella AP.

Int Rev Neurobiol. 2013;112:73-93. doi: 10.1016/B978-0-12-411546-0.00003-2.

PMID:
24295618
[PubMed - indexed for MEDLINE]
17.

An introduction to the clinical phenomenology of Tourette syndrome.

Martino D, Madhusudan N, Zis P, Cavanna AE.

Int Rev Neurobiol. 2013;112:1-33. doi: 10.1016/B978-0-12-411546-0.00001-9. Review.

PMID:
24295616
[PubMed - indexed for MEDLINE]
18.

Deep brain stimulation for Tourette syndrome.

Kim W, Pouratian N.

Neurosurg Clin N Am. 2014 Jan;25(1):117-35. doi: 10.1016/j.nec.2013.08.009. Epub 2013 Oct 8. Review.

PMID:
24262904
[PubMed - indexed for MEDLINE]
19.

Tourette syndrome in a patient with resistance to thyroid hormone syndrome.

Monzani A, Bona G, Moia S, Corrias A, Miglio C, Cavanna AE.

J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):E09-10. doi: 10.1176/appi.neuropsych.12090210. No abstract available.

PMID:
24247869
[PubMed - indexed for MEDLINE]
20.

Gilles de la Tourette syndrome.

Gravino G.

Ann Clin Psychiatry. 2013 Nov;25(4):297-306. Review.

PMID:
24199221
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk